# DaVita Inc. – Consensus ‘hold’ rating and 16.8% Upside Potential

- Link: https://www.directorstalkinterviews.com/davita-inc.consensus-hold-rating-and-16.8-upside-potential/4121127530
- Published: 2023-09-19T13:33:30+01:00
- Author: Charlotte Edwards

**DaVita Inc.** with ticker code (DVA) have now 6 market analysts covering the stock.
The analyst consensus now points to a rating of ‘hold’. The range between the high
target price and low target price is between 142 and 100 and has a mean target at
$114.83. Given that the stocks previous close was at $98.33 this is indicating there
is a potential upside of 16.8%. The 50 day moving average now sits at $102.62 and
the 200 day MA is $89.41. The market cap for the company is 9.11B. The stock price
is currently at: 99.77 USD

 The potential market cap would be $10,637,511,360 based on the market consensus.

The company has a dividend yield of 3.8%. Other points of data to note are a P/E
ratio of 20.03, revenue per share of 129.46 and a 4.62% return on assets.

DaVita Inc. is a healthcare provider. The Company provides kidney care services 
in the United States. The Company’s operations are comprised of its U.S. dialysis
and related lab services business (its U.S. dialysis business), its U.S. integrated
kidney care business, its U.S. other ancillary services and its international operations(
its ancillary services). The U.S. dialysis and related lab services (U.S. dialysis)
business treats patients with chronic kidney failure, and end-stage kidney disease(
ESKD). Its services include outpatient hemodialysis services, hospital inpatient
hemodialysis services, and home-based dialysis services. The ancillary services 
consist of integrated kidney care services, physician services, clinical research
programs, and transplant software business, as well as international operations.
The Company operates approximately 2,724 outpatient dialysis centers in the United
States.

Share on: